Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
The preclinical evaluation of angiogenesis inhibitors
Michael S. O'Reilly
Research output
:
Contribution to journal
›
Review article
›
peer-review
37
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The preclinical evaluation of angiogenesis inhibitors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Angiogenesis Inhibitors
100%
Physiological Phenomena
43%
Drug Resistance
38%
Clinical Trials
27%
Growth
20%
Neoplasms
13%
Therapeutics
6%